MEDGENICS INC - COM NEW (MDGN)

CUSIP: 58436Q203

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM NEW
Total 13F shares
7,029,561
Share change
+839,147
Total reported value
$54,933,095
Put/Call ratio
2.9%
Price per share
$7.82
Number of holders
49
Value change
+$7,485,873
Number of buys
30
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 58436Q203?
CUSIP 58436Q203 identifies MDGN - MEDGENICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MEDGENICS INC - COM NEW (MDGN) as of Q3 2015

As of 30 Sep 2015, MEDGENICS INC - COM NEW (MDGN) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,029,561 shares. The largest 10 holders included Broadfin Capital, LLC, Opaleye Management Inc., JENNISON ASSOCIATES LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, BAILLIE GIFFORD & CO, QVT Financial LP, NORTHERN TRUST CORP, and STATE STREET CORP. This page lists 49 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.